Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 20/20 | 0.85 |
| ▸ | F2 | P00734 | 5/20 | 0.85 |
| ▸ | PRSS1 | P07477 | 5/20 | 0.85 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4352256 | 0.80 | F10 (1.00) | F10F2PRSS1 | |
| SCHEMBL4352253 | 0.80 | F10 (1.00) | F10F2PRSS1 | |
| SCHEMBL7688293 | 0.79 | F10 (1.00) | F10F2PRSS1KCNH2 | |
| SCHEMBL7690621 | 0.79 | F10 (1.00) | F10F2PRSS1KCNH2 | |
| SCHEMBL4096654 | 0.77 | F10 (0.62) | F10F2PRSS1 | |
| SCHEMBL4096651 | 0.77 | F10 (0.62) | F10F2PRSS1 | |
| SCHEMBL7684143 | 0.76 | F10 (1.00) | F10F2PRSS1KCNH2 | |
| SCHEMBL7684142 | 0.76 | F10 (1.00) | F10F2PRSS1KCNH2 | |
| SCHEMBL7690881 | 0.71 | F10 (1.00) | F10F2PRSS1 | |
| SCHEMBL7690879 | 0.71 | F10 (1.00) | F10F2PRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090285887-A1 | Pharmaceutical Composition Comprising A Plurality of Mini-Tablets Comprising A Factor XA Inhibitor | GLAXO GROUP LIMITED (GB) | 2009-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090285887-A1 | Pharmaceutical Composition Comprising A Plurality of Mini-Tablets Comprising A Factor XA Inhibitor | F12, TFPI, PLAT | F10 11/4885F2 10/4885PRSS1 79/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.